What is Healthcare Services Group's earnings per share (EPS)?

Healthcare Services Group (HCSG) reported diluted earnings per share of $0.81 for fiscal year 2025. This represents a 52.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Healthcare Services Group (HCSG) Financials

HCSG NASDAQ

Trailing 12 months to September 30, 2026

Revenue $1.9B +4.0% YoY

Net Income $104.9M +163.9% YoY

EPS (Diluted) $1.48 +174.1% YoY

Free Cash Flow $106.7M -32.4% YoY

Market Cap $1.7B as of Oct 26, 2026

Price / Sales 0.9x on $1.9B revenue, trailing 12 months to September 30, 2026

Price / Earnings 16.2x on $104.9M net income, trailing 12 months to September 30, 2026

Price / Book 3.2x on $531.5M equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 26, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Oct 23, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Oct 23, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the HCSG SEC filings page.

Healthcare Services Group (HCSG) reported $1.9B in revenue over the twelve months to Sep 30, 2026, up 4.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HCSG FY2025 2026-10-23

FY2025 shows a low-margin service business whose cash generation surged while liabilities fell, reshaping how the balance sheet is financed in practice.

Cash conversion strengthened sharply: operating cash flow reached $145M against net income of $59M in FY2025, after conversion had been weaker in the prior year. Receivables fell 15.0% to $281M, so the cash surge appears tied partly to collecting working capital rather than merely higher accounting profit.

FY2025 revenue grew 7.1% while gross-profit margin slipped 0.3 percentage points; growth therefore did not come from a wider service spread. Net margin nevertheless improved 0.9 percentage points as interest expense fell 75.5%, pointing to below-gross-profit items doing more work than margin expansion.

Balance-sheet obligations became lighter: liabilities were 35.8% of assets in FY2025, down from 42.9% in FY2021. The current ratio reached 3.4x, reinforcing that stronger cash generation sits alongside greater short-term financial flexibility and less liability dependence than earlier periods.

Financial Health Signals

Financial Health Score 61/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Healthcare Services Group's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Growth

Healthcare Services Group's revenue grew 7.1% year-over-year to $1.8B, a solid pace of expansion. This earns a growth score of 49/100.

Leverage

Liquidity

With a current ratio of 3.38, Healthcare Services Group holds $3.38 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 82/100.

Cash Flow

Healthcare Services Group has a free cash flow margin of 7.6%, earning a moderate score of 44/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Healthcare Services Group earns a strong 11.6% return on equity (ROE), meaning it generates $12 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 76/100. This is up from 7.9% the prior year.

Piotroski F-Score Partial

7/8

Healthcare Services Group passes 7 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 2 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.

Earnings Quality Cash-Backed

2.45x

For every $1 of reported earnings, Healthcare Services Group generates $2.45 in operating cash flow ($145.0M OCF vs $59.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$479.6M

YoY+3.3%

QoQ+1.9%

5Y CAGR+2.9%

10Y CAGR+2.0%

Healthcare Services Group generated $479.6M in revenue in Q3 2026. This represents an increase of 3.3% from the same quarter a year earlier. Against the prior quarter it is up 1.9%.

Net Income

$24.9M

YoY-42.1%

QoQ+9.6%

5Y CAGR+21.1%

10Y CAGR+2.4%

Healthcare Services Group reported $24.9M in net income in Q3 2026. This represents a decrease of 42.1% from the same quarter a year earlier. Against the prior quarter it is up 9.6%.

EPS (Diluted)

$0.36

YoY-39.0%

QoQ+12.5%

Healthcare Services Group earned $0.36 per diluted share (EPS) in Q3 2026. This represents a decrease of 39.0% from the same quarter a year earlier. Against the prior quarter it is up 12.5%.

EBITDA

Not reported for Q3 2026.

Cash & Balance Sheet

Free Cash Flow

$28.1M

YoY-59.8%

QoQ+38.8%

5Y CAGRn/m

10Y CAGR+5.3%

Healthcare Services Group generated $28.1M in free cash flow in Q3 2026, representing cash available after capex. This represents a decrease of 59.8% from the same quarter a year earlier. Against the prior quarter it is up 38.8%.

Cash & Debt

$134.6M

YoY+8.2%

QoQ+9.1%

5Y CAGR+11.1%

10Y CAGR+18.7%

Healthcare Services Group held $134.6M in cash as of Q3 2026; no long-term debt figure is on record for that period.

Shares Outstanding

67M

YoY-4.3%

QoQ-1.7%

Healthcare Services Group had 67M shares outstanding in Q3 2026. This represents a decrease of 4.3% from the same quarter a year earlier. Against the prior quarter it is down 1.7%.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin

16.8%

YoY-4.0pp

QoQ+0.9pp

5Y change+4.5pp

Healthcare Services Group's gross margin was 16.8% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is down 4.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.9 percentage points.

Net Margin

5.2%

YoY-4.1pp

QoQ+0.4pp

5Y change+2.9pp

10Y change+0.2pp

Healthcare Services Group's net profit margin was 5.2% in Q3 2026, showing the share of revenue converted to profit. This is down 4.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.4 percentage points.

Return on Equity

4.7%

YoY-4.0pp

QoQ+0.3pp

5Y change+2.7pp

10Y change-1.3pp

Healthcare Services Group's quarterly ROE was 4.7% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is down 4.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.

Operating Margin

Not reported for Q3 2026.

Capital Allocation

Share Buybacks

$11.7M

YoY-57.0%

QoQ-43.9%

5Y CAGR+26.9%

Healthcare Services Group spent $11.7M on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 57.0% from the same quarter a year earlier. Against the prior quarter it is down 43.9%.

Capital Expenditures

$2.1M

YoY+54.9%

QoQ+26.9%

5Y CAGR-0.4%

10Y CAGR+8.0%

Healthcare Services Group invested $2.1M in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 54.9% from the same quarter a year earlier. Against the prior quarter it is up 26.9%.

R&D Spending

Not reported for Q3 2026.

HCSG Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HCSG quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$1.9B	$1.8B+7.1%	$1.7B+2.7%	$1.7B-1.1%	$1.7B+2.9%	$1.6B-6.7%	$1.8B-4.4%	$1.8B-8.1%	$2.0B+7.6%	$1.9B+19.1%	$1.6B+8.8%	$1.4B+11.1%	$1.3B+12.5%	$1.1B+6.7%	$1.1B+21.2%	$889.1M
Cost of Revenue	$1.6B	$1.6B+7.4%	$1.5B+2.1%	$1.5B-2.7%	$1.5B+6.1%	$1.4B-5.4%	$1.5B-7.5%	$1.6B-8.8%	$1.8B+9.8%	$1.6B+20.2%	$1.3B	N/A	N/A	N/A	N/A	N/A
Gross Profit	$303.1M	$239.4M+5.0%	$228.1M+6.2%	$214.7M+11.1%	$193.3M-16.2%	$230.6M-14.0%	$268.0M+17.6%	$227.9M-2.8%	$234.4M-6.5%	$250.6M+12.3%	$223.2M	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$189.2M	$190.9M+4.3%	$183.1M+9.8%	$166.8M+18.8%	$140.3M-18.9%	$173.1M+14.8%	$150.8M+0.5%	$150.0M+9.8%	$136.6M+7.8%	$126.7M+20.2%	$105.4M-5.6%	$111.7M+3.6%	$107.8M+17.2%	$92.0M+16.0%	$79.3M+21.4%	$65.3M
Interest Expense	$1.7M	$1.6M-75.5%	$6.4M-18.0%	$7.9M+163.0%	$3.0M+115.7%	$1.4M+0.8%	$1.4M-60.3%	$3.5M+11.8%	$3.1M+127.0%	$1.4M	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$22.9M	$8.8M-34.6%	$13.5M-8.2%	$14.7M+42.3%	$10.3M-39.2%	$17.0M-44.4%	$30.5M+48.7%	$20.5M+25.2%	$16.4M-63.4%	$44.7M+4.1%	$43.0M+35.4%	$31.7M+222.0%	$9.9M-49.1%	$19.4M-25.7%	$26.1M+32.5%	$19.7M
Net Income	$104.9M	$59.1M+49.6%	$39.5M+2.8%	$38.4M+12.1%	$34.2M-29.5%	$48.5M-50.8%	$98.7M+52.8%	$64.6M-22.7%	$83.5M-5.3%	$88.2M+14.0%	$77.4M+33.4%	$58.0M+165.6%	$21.9M-53.6%	$47.1M+6.6%	$44.2M+15.9%	$38.2M
EPS (Basic)	N/A	$0.82+51.9%	$0.54+3.8%	$0.52+13.0%	$0.46-29.2%	$0.65-50.8%	$1.32+51.7%	$0.87-23.0%	$1.13-5.8%	$1.20+13.2%	$1.06+30.9%	$0.81+161.3%	$0.31-54.4%	$0.68+4.6%	$0.65+14.0%	$0.57
EPS (Diluted)	$1.48	$0.81+52.8%	$0.53+1.9%	$0.52+13.0%	$0.46-29.2%	$0.65-50.8%	$1.32+51.7%	$0.87-22.3%	$1.12-5.9%	$1.19+13.3%	$1.05+31.3%	$0.80+158.1%	$0.31-53.7%	$0.67+3.1%	$0.65+16.1%	$0.56
Diluted Shares (Avg)	N/A	73M-1.3%	74M-0.5%	74M0.0%	74M-0.8%	75M+0.2%	75M+0.3%	75M0.0%	75M+0.4%	74M+1.2%	73M+1.3%	73M+1.6%	71M+1.9%	70M+2.3%	68M+1.3%	68M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Revenue	$479.6M+3.3%	$470.8M+2.7%	$462.8M+3.4%	$466.7M+6.6%	$464.3M+8.5%	$458.5M+7.6%	$447.7M+5.7%	$437.8M+3.3%
Cost of Revenue	$399.2M+8.5%	$396.0M-13.1%	$386.9M+1.9%	$394.6M+4.1%	$367.9M+0.9%	$455.5M+18.4%	$379.7M+5.8%	$379.2M+8.6%
Gross Profit	$80.4M-16.6%	$74.8M+2428.5%	$75.8M+11.6%	$72.1M+23.0%	$96.4M+52.0%	$3.0M-92.9%	$68.0M+5.3%	$58.6M-21.6%
SG&A Expenses	$48.5M-4.1%	$52.6M+7.0%	$42.0M-6.6%	$46.2M+3.1%	$50.5M+7.8%	$49.2M+10.6%	$45.0M-4.1%	$44.8M-3.1%
Interest Expense	$318K-19.1%	$619K+48.1%	$365K-7.6%	$374K-68.3%	$393K-74.6%	$418K-75.6%	$395K-80.2%	$1.2M-42.8%
Income Tax	$8.9M-38.3%	$8.3Mn/m	$8.5M+27.2%	-$2.7M-193.3%	$14.4M+200.4%	-$9.5Mn/m	$6.7M+11.0%	$2.9M-67.2%
Net Income	$24.9M-42.1%	$22.7Mn/m	$26.1M+51.3%	$31.2M+162.1%	$43.0M+206.2%	-$32.4Mn/m	$17.2M+12.5%	$11.9M-49.3%
EPS (Basic)	$0.37-37.3%	$0.33n/m	$0.37+60.9%	$0.44+158.8%	$0.59+210.5%	-$0.44n/m	$0.23+9.5%	$0.17-45.2%
EPS (Diluted)	$0.36-39.0%	$0.32n/m	$0.37+60.9%	$0.43+168.8%	$0.59+210.5%	-$0.44n/m	$0.23+9.5%	$0.16-48.4%
Diluted Shares (Avg)	69M-4.9%	70M-4.5%	71M-3.9%	N/A	73M-1.3%	73M-0.9%	74M-0.1%	N/A

Not reported in any period shown, so not listed: R&D Expenses, Operating Income, EBITDA.

HCSG Balance Sheet

HCSG quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$794.3M-1.1%	$802.8M+1.5%	$790.7M+9.7%	$720.8M-7.6%	$779.9M-0.7%	$785.0M+8.6%	$722.6M+4.3%	$692.6M+2.5%	$676.0M+27.9%	$528.4M+9.9%	$480.9M+2.4%	$469.6M+10.4%	$425.3M+28.4%	$331.2M+14.3%	$289.7M
Current Assets	$576.4M+3.6%	$556.7M-2.6%	$571.7M+12.4%	$508.6M-6.9%	$546.4M-4.5%	$572.4M+11.0%	$515.7M+1.5%	$508.1M-3.7%	$527.4M+27.2%	$414.6M+13.5%	$365.3M+9.1%	$334.8M+8.3%	$309.2M+15.4%	$267.8M+15.4%	$232.1M
Cash & Equivalents	$125.2M+120.5%	$56.8M+4.5%	$54.3M+106.7%	$26.3M-62.9%	$70.8M-49.2%	$139.3M+409.8%	$27.3M+5.0%	$26.0M+172.3%	$9.6M-59.9%	$23.9M-28.1%	$33.2M-55.9%	$75.3M+17.3%	$64.2M-7.0%	$68.9M+78.4%	$38.6M
Short-Term Investments	$42.8M-15.4%	$50.5M-45.7%	$93.1M-2.2%	$95.2M-16.8%	$114.4M-8.5%	$125.0M+37.8%	$90.7M+18.8%	$76.4M+4.3%	$73.2M+8.1%	$67.7M-2.5%	$69.5M+489.0%	$11.8M+3.1%	$11.4M-46.3%	$21.3M-32.0%	$31.3M
Inventory	$16.8M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$281.3M-15.0%	$330.9M-4.0%	$344.9M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0
Goodwill	$79.8M+5.7%	$75.5M0.0%	$75.5M0.0%	$75.5M+1.0%	$74.8M+46.3%	$51.1M0.0%	$51.1M0.0%	$51.1M0.0%	$51.1M+15.0%	$44.4M0.0%	$44.4M0.0%	$44.4M+10.6%	$40.2M+137.0%	$17.0M0.0%	$17.0M
Total Liabilities	$284.0M-6.2%	$302.8M-9.3%	$334.0M+10.4%	$302.6M-9.6%	$334.7M+6.3%	$314.8M+20.0%	$262.3M+4.2%	$251.8M-8.8%	$276.1M+45.6%	$189.6M+2.8%	$184.5M-4.8%	$193.7M+38.2%	$140.2M+38.0%	$101.6M+41.2%	$72.0M
Current Liabilities	$170.4M-11.5%	$192.5M-11.2%	$216.9M+14.8%	$189.0M-1.1%	$191.1M+17.8%	$162.3M+9.2%	$148.7M-9.0%	$163.4M-11.3%	$184.2M+82.6%	$100.9M+5.0%	$96.1M-18.6%	$118.0M+19.0%	$99.1M+46.5%	$67.7M+49.1%	$45.4M
Non-Current Liabilities	$113.7M+3.1%	$110.3M-5.8%	$117.1M+3.1%	$113.5M-20.9%	$143.6M-5.8%	$152.5M+34.2%	$113.6M+28.5%	$88.4M-3.8%	$91.9M+3.5%	$88.7M+0.3%	$88.4M+16.7%	$75.8M+84.4%	$41.1M+21.1%	$33.9M+27.7%	$26.6M
Total Equity	$510.2M+2.1%	$499.9M+9.5%	$456.6M+9.2%	$418.3M-6.0%	$445.2M-5.3%	$470.3M+2.2%	$460.3M+4.4%	$440.8M+10.2%	$400.0M+18.0%	$338.8M+14.3%	$296.5M+7.5%	$275.8M-3.3%	$285.1M+24.2%	$229.6M+5.4%	$217.7M
Retained Earnings	$283.7M+26.3%	$224.6M+21.4%	$185.0M+26.2%	$146.6M-20.3%	$184.0M-8.4%	$200.9M+2.8%	$195.5M+2.8%	$190.1M+16.0%	$163.9M+25.1%	$130.9M+22.5%	$106.9M+6.6%	$100.2M-21.4%	$127.5M+0.3%	$127.0M+0.1%	$126.9M

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Total Assets	$850.4M+5.7%	$820.9M+2.3%	$814.8M-1.0%	$794.3M-1.1%	$804.3M-0.2%	$802.2M+0.3%	$823.0M+2.4%	$802.8M+1.5%
Current Assets	$582.8M+0.4%	$568.5M+6.8%	$601.2M+4.6%	$576.4M+3.6%	$580.6M+0.4%	$532.3M-7.1%	$575.0M-0.9%	$556.7M-2.6%
Cash & Equivalents	$134.6M+8.2%	$123.4M+49.0%	$136.2M+111.7%	$125.2M+120.5%	$124.4M+359.8%	$82.8M+213.3%	$64.3M+119.6%	$56.8M+4.5%
Short-Term Investments	$34.2M-35.5%	$41.3M-20.0%	$42.4M-15.9%	$42.8M-15.4%	$53.1M-30.9%	$51.7M-34.7%	$50.5M-33.2%	$50.5M-45.7%
Inventory	$15.5M	$15.8M	N/A	$16.8M	N/A	N/A	N/A	N/A
Accounts Receivable	$309.6M+7.3%	$292.8M+0.2%	$299.4M-11.4%	$281.3M-15.0%	$288.5M	$292.2M	$337.9M	$330.9M-4.0%
Long-Term Investments	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m	$0n/m
Goodwill	$90.5M+13.0%	$85.8M+7.2%	$79.8M-0.3%	$79.8M+5.7%	$80.1M+6.0%	$80.0M+6.0%	$80.0M+6.0%	$75.5M0.0%
Total Liabilities	$318.9M+3.5%	$302.0M-7.1%	$301.1M-2.5%	$284.0M-6.2%	$308.3M-2.8%	$325.2M-0.9%	$308.8M-6.2%	$302.8M-9.3%
Current Liabilities	$206.4M+5.5%	$188.1M-12.1%	$193.4M-2.7%	$170.4M-11.5%	$195.6M-0.8%	$213.9M+2.1%	$198.7M-5.1%	$192.5M-11.2%
Non-Current Liabilities	$112.5M-0.1%	$113.9M+2.4%	$107.7M-2.1%	$113.7M+3.1%	$112.7M-6.0%	$111.2M-6.4%	$110.0M-8.3%	$110.3M-5.8%
Total Equity	$531.5M+7.1%	$518.8M+8.8%	$513.8M-0.1%	$510.2M+2.1%	$496.0M+1.5%	$477.0M+1.2%	$514.2M+8.3%	$499.9M+9.5%
Retained Earnings	$357.3M+41.5%	$332.4M+58.7%	$309.7M+28.1%	$283.7M+26.3%	$252.4M+18.7%	$209.5M+5.5%	$241.8M+20.7%	$224.6M+21.4%

Not reported in any period shown, so not listed: Long-Term Debt.

HCSG Cash Flow Statement

HCSG quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$113.2M	$145.0M+370.6%	$30.8M-29.2%	$43.5Mn/m	-$8.2M-122.0%	$37.1M-82.9%	$217.2M+132.1%	$93.6M+16.9%	$80.0M+948.9%	$7.6M-81.6%	$41.4M-34.7%	$63.4M+9.8%	$57.7M+79.5%	$32.2M-46.7%	$60.4M+83.2%	$32.9M
Depreciation & Amortization	N/A	$16.8M+15.0%	$14.6M+1.7%	$14.3M-6.3%	$15.3M+4.4%	$14.7M+2.8%	$14.3M+2.4%	$13.9M+50.3%	$9.3M+4.3%	$8.9M+18.5%	$7.5M-2.1%	$7.7M+5.4%	$7.3M+17.2%	$6.2M+21.3%	$5.1M+16.6%	$4.4M
Stock-Based Compensation	N/A	$12.0M+31.0%	$9.2M+2.0%	$9.0M-2.5%	$9.2M+4.4%	$8.8M+12.1%	$7.9M+14.7%	$6.9M+16.4%	$5.9M-1.4%	$6.0M+40.8%	$4.3M+154.9%	$1.7M-45.8%	$3.1M+18.1%	$2.6M+2.7%	$2.5M+17.9%	$2.2M
Capital Expenditures	$6.5M	$5.8M-8.2%	$6.3M+17.2%	$5.4M+3.8%	$5.2M-8.4%	$5.7M+31.0%	$4.3M-0.6%	$4.4M-11.6%	$4.9M-8.5%	$5.4M-0.8%	$5.4M+8.9%	$5.0M-13.8%	$5.8M+54.0%	$3.8M+8.0%	$3.5M-37.2%	$5.5M
Free Cash Flow	$106.7M	$139.2M+468.7%	$24.5M-35.8%	$38.1Mn/m	-$13.4M-142.6%	$31.4M-85.2%	$212.9M+138.6%	$89.2M+18.8%	$75.1M+3262.8%	$2.2M-93.8%	$36.0M-38.4%	$58.4M+12.4%	$51.9M+82.9%	$28.4M-50.1%	$56.9M+107.6%	$27.4M
Investing Cash Flow	-$24.0M	-$11.0M-282.0%	$6.0Mn/m	-$3.3M-227.6%	$2.6Mn/m	-$23.0Mn/m	-$36.8Mn/m	-$16.5Mn/m	-$9.6Mn/m	-$15.0Mn/m	-$6.5Mn/m	-$62.3Mn/m	-$6.5M-1167.8%	$605K-89.4%	$5.7M+26.0%	$4.5M
Financing Cash Flow	-$78.9M	-$63.3Mn/m	-$31.0Mn/m	-$12.2Mn/m	-$38.9Mn/m	-$82.7Mn/m	-$68.4Mn/m	-$75.8Mn/m	-$54.0Mn/m	-$7.0Mn/m	-$44.3Mn/m	-$43.1Mn/m	-$40.1Mn/m	-$37.6Mn/m	-$35.8Mn/m	-$38.5M
Dividends Paid	N/A	N/A	$0n/m	$0-100.0%	$63.4M+1.8%	$62.2M+2.5%	$60.7M+3.0%	$59.0M+3.1%	$57.2M+3.5%	$55.2M+3.6%	$53.3M+3.8%	$51.4M+4.7%	$49.1M+5.1%	$46.7M+5.9%	$44.1M+4.4%	$42.2M
Share Buybacks	$76.2M	$61.6M+1127.3%	$5.0M-55.5%	$11.3Mn/m	$0-100.0%	$21.5Mn/m	$0n/m	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Operating Cash Flow	$30.2M-57.7%	$21.9M-24.0%	$43.7M+59.0%	$17.4M-52.0%	$71.3M+1553.4%	$28.8M+76.4%	$27.5Mn/m	$36.2M-26.8%
Depreciation & Amortization	$4.1M0.0%	$3.5M-30.0%	$3.8M-1.9%	$3.9M+7.4%	$4.1M+7.9%	$5.0M+35.1%	$3.9M+9.8%	$3.6M-4.7%
Stock-Based Compensation	N/A	N/A	$2.8M-26.1%	N/A	N/A	N/A	$3.7M+50.5%	N/A
Capital Expenditures	$2.1M+54.9%	$1.6M+19.9%	$1.4M-19.8%	$1.4M-3.3%	$1.3M-4.5%	$1.4M+3.6%	$1.7M-20.7%	$1.4M-0.4%
Free Cash Flow	$28.1M-59.8%	$20.2M-26.2%	$42.3M+64.3%	$16.0M-54.0%	$70.0M+2301.5%	$27.4M+82.8%	$25.8Mn/m	$34.8M-27.6%
Investing Cash Flow	-$7.2Mn/m	-$13.8Mn/m	-$11.5Mn/m	$8.6M-60.7%	-$2.7M-1053.5%	-$2.4Mn/m	-$14.5M-223.5%	$21.8Mn/m
Financing Cash Flow	-$11.7Mn/m	-$20.9Mn/m	-$26.7Mn/m	-$19.6Mn/m	-$27.3Mn/m	-$7.7Mn/m	-$8.8M-162.8%	-$26.0Mn/m
Share Buybacks	$11.7M-57.0%	$20.9M+172.7%	$24.0M+240.6%	$19.6M+1841.0%	$27.3M+2605.5%	$7.7M+155.8%	$7.0Mn/m	$1.0M-80.0%

Not reported in any period shown, so not listed: Dividends Paid.

HCSG Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HCSG quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	13.0%-0.3pp	13.3%+0.4pp	12.8%+1.4pp	11.4%-2.6pp	14.0%-1.2pp	15.2%+2.8pp	12.4%+0.7pp	11.7%-1.8pp	13.5%-0.8pp	14.3%	N/A	N/A	N/A	N/A	N/A
Net Margin	3.2%+0.9pp	2.3%0.0pp	2.3%+0.3pp	2.0%-0.9pp	3.0%-2.6pp	5.6%+2.1pp	3.5%-0.7pp	4.2%-0.6pp	4.7%-0.2pp	5.0%+0.9pp	4.0%+2.4pp	1.7%-2.4pp	4.1%0.0pp	4.1%-0.2pp	4.3%
Return on Equity	11.6%+3.7pp	7.9%-0.5pp	8.4%+0.2pp	8.2%-2.7pp	10.9%-10.1pp	21.0%+6.9pp	14.0%-4.9pp	18.9%-3.1pp	22.1%-0.8pp	22.8%+3.3pp	19.6%+11.7pp	7.9%-8.6pp	16.5%-2.7pp	19.3%+1.7pp	17.5%
Return on Assets	7.4%+2.5pp	4.9%+0.1pp	4.9%+0.1pp	4.8%-1.5pp	6.2%-6.3pp	12.6%+3.6pp	8.9%-3.1pp	12.1%-1.0pp	13.1%-1.6pp	14.6%+2.6pp	12.1%+7.4pp	4.7%-6.4pp	11.1%-2.3pp	13.4%+0.2pp	13.2%
Current Ratio	3.38+0.5x	2.89+0.3x	2.64-0.1x	2.69-0.2x	2.86-0.7x	3.53+0.1x	3.47+0.4x	3.11+0.2x	2.86-1.2x	4.11+0.3x	3.80+1.0x	2.84-0.3x	3.12-0.8x	3.96-1.2x	5.11
Liabilities-to-Equity	0.560.0x	0.61-0.1x	0.730.0x	0.720.0x	0.75+0.1x	0.67+0.1x	0.570.0x	0.57-0.1x	0.69+0.1x	0.56-0.1x	0.62-0.1x	0.70+0.2x	0.490.0x	0.44+0.1x	0.33
Asset Turnover	2.31+0.2x	2.140.0x	2.11-0.2x	2.34+0.2x	2.11-0.1x	2.24-0.3x	2.55-0.3x	2.89+0.1x	2.75-0.2x	2.960.0x	2.99+0.2x	2.75+0.1x	2.70-0.5x	3.25+0.2x	3.07
FCF Margin	7.6%+6.1pp	1.4%-0.9pp	2.3%+3.1pp	-0.8%-2.7pp	1.9%-10.2pp	12.1%+7.2pp	4.9%+1.1pp	3.8%+3.6pp	0.1%-2.2pp	2.3%-1.8pp	4.1%0.0pp	4.0%+1.6pp	2.5%-2.8pp	5.3%+2.2pp	3.1%

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Gross Margin	16.8%-4.0pp	15.9%+15.2pp	16.4%+1.2pp	15.4%+2.1pp	20.8%+5.9pp	0.7%-9.1pp	15.2%-0.1pp	13.4%-4.2pp
Net Margin	5.2%-4.1pp	4.8%+11.9pp	5.6%+1.8pp	6.7%+4.0pp	9.3%+6.0pp	-7.1%-6.6pp	3.9%+0.2pp	2.7%-2.8pp
Return on Equity	4.7%-4.0pp	4.4%+11.2pp	5.1%+1.7pp	6.1%+3.7pp	8.7%+5.8pp	-6.8%-6.4pp	3.4%+0.1pp	2.4%-2.8pp
Return on Assets	2.9%-2.4pp	2.8%+6.8pp	3.2%+1.1pp	3.9%+2.5pp	5.3%+3.6pp	-4.0%-3.8pp	2.1%+0.2pp	1.5%-1.5pp
Current Ratio	2.82-0.1x	3.02+0.5x	3.11+0.2x	3.38+0.5x	2.970.0x	2.49-0.2x	2.89+0.1x	2.89+0.3x
Liabilities-to-Equity	0.600.0x	0.58-0.1x	0.590.0x	0.560.0x	0.620.0x	0.680.0x	0.60-0.1x	0.61-0.1x
Asset Turnover	0.560.0x	0.570.0x	0.570.0x	0.590.0x	0.580.0x	0.570.0x	0.540.0x	0.550.0x
FCF Margin	5.9%-9.2pp	4.3%-1.7pp	9.2%+3.4pp	3.4%-4.5pp	15.1%+14.4pp	6.0%+2.5pp	5.8%+12.4pp	7.9%-3.4pp

Not reported in any period shown, so not listed: Operating Margin, Debt-to-Equity.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Healthcare Services Group HCSG	FY2025	$1.8B	$59.1M	3.2%	$1.7B	61/100
PACS Group, Inc. PACS	FY2025	$5.3B	$191.5M	3.6%	$7.7B	58/100
US Physical Therapy Inc USPH	FY2025	$781.0M	$39.6M	5.1%	$1.3B	55/100
Pediatrix Medical Group, Inc. MD	FY2025	$1.9B	$165.4M	8.6%	$2.4B	41/100
Astrana Health Inc. ASTH	FY2025	$3.2B	$22.5M	0.7%	$1.8B	48/100
Aveanna Healthcare Holdings Inc. AVAH	FY2026	$2.4B	$225.0M	9.3%	$2.9B	43/100

Where Healthcare Services Group Ranks

Frequently Asked Questions

What is Healthcare Services Group's annual revenue?

Healthcare Services Group (HCSG) reported $1.8B in total revenue for fiscal year 2025. This represents a 7.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Healthcare Services Group's revenue growing?

Healthcare Services Group (HCSG) revenue grew by 7.1% year-over-year, from $1.7B to $1.8B in fiscal year 2025.

Is Healthcare Services Group profitable?

Yes, Healthcare Services Group (HCSG) reported a net income of $104.9M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $59.1M, with a net profit margin of 3.2%.

What is Healthcare Services Group's gross margin?

Healthcare Services Group (HCSG) had a gross margin of 13.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Healthcare Services Group's net profit margin?

Healthcare Services Group (HCSG) had a net profit margin of 3.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Healthcare Services Group's return on equity (ROE)?

Healthcare Services Group (HCSG) has a return on equity of 11.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Healthcare Services Group's free cash flow?

Healthcare Services Group (HCSG) generated $139.2M in free cash flow during fiscal year 2025. This represents a 468.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Healthcare Services Group's operating cash flow?

Healthcare Services Group (HCSG) generated $145.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Healthcare Services Group's total assets?

Healthcare Services Group (HCSG) had $794.3M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Healthcare Services Group's capital expenditures?

Healthcare Services Group (HCSG) invested $5.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Healthcare Services Group buy back shares?

Yes, Healthcare Services Group (HCSG) spent $61.6M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Healthcare Services Group have outstanding?

Healthcare Services Group (HCSG) had 70M shares outstanding as of fiscal year 2025.

What is Healthcare Services Group's current ratio?

Healthcare Services Group (HCSG) had a current ratio of 3.38 as of fiscal year 2025, which is generally considered healthy.

What is Healthcare Services Group's liabilities-to-equity ratio?

Healthcare Services Group (HCSG) had a liabilities-to-equity ratio of 0.56 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.

What is Healthcare Services Group's return on assets (ROA)?

Healthcare Services Group (HCSG) had a return on assets of 7.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Healthcare Services Group's P/E ratio?

Healthcare Services Group (HCSG) trades at 16.2x earnings, its market capitalization divided by $104.9M net income, trailing 12 months to September 30, 2026. The market capitalization is $1.7B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Healthcare Services Group's price-to-sales ratio?

Healthcare Services Group (HCSG) trades at 0.9x sales, its market capitalization divided by $1.9B revenue, trailing 12 months to September 30, 2026. The market capitalization is $1.7B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Healthcare Services Group's Piotroski F-Score?

Healthcare Services Group (HCSG) has a Piotroski F-Score of 7 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Healthcare Services Group's earnings high quality?

Healthcare Services Group (HCSG) has an earnings quality ratio of 2.45x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Healthcare Services Group?

Healthcare Services Group (HCSG) scores 61 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.